Trials / Completed
CompletedNCT00000342
Risperidone for the Treatment of Cocaine Dependence - 7
Risperidone for the Treatment of Cocaine Dependence
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate clinical safety and pharmacological efficacy in the treatment of cocaine dependence, to evaluate impact of treatment on craving, and to correlate evidence of baseline neurotoxic damage of cocaine with treatment outcome and clinical side-effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Risperidone |
Timeline
- Start date
- 1996-07-01
- Primary completion
- 1997-08-01
- Completion
- 1997-09-01
- First posted
- 1999-09-21
- Last updated
- 2017-01-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000342. Inclusion in this directory is not an endorsement.